The independent platform for news, articles and advice for professionals in laboratory medicine

Don’t Wait;Act testing campaign launched by BIVDA

The British In Vitro Diagnostics Association (BIVDA) has launched its new Don’t Wait;Act campaign to re-start testing for non-COVID health issues.

Routine care and health screening for diseases such as cancer, heart disease and diabetes have either experienced long pauses or drops in take-ups from members of the public during the SARS-CoV-2 pandemic. As a result, thousands of people could be living with potentially life-threatening undiagnosed diseases.

The campaign seeks to encourage the public to attend test appointments without hesitating over COVID-related safety concerns at healthcare settings and to act swiftly on any worrying signs of symptoms of ill health. Many people who have long-term conditions and need tests to monitor their disease may also have been missing blood tests and we hope this campaign will remind them of their importance. 

Some BIVDA member companies saw a 70% drop in routine demand for their diagnostic products during the early stages of the pandemic in 2020. Every cancelled order meant that there were patients not being given a vital test that could uncover an undiagnosed condition.

The campaign will be social media-focused, and any organisations who would like to join with BIVDA are very welcome sharing visual and written content around the issue of restarting diagnostic appointments.

BIVDA has worked with its membership to compile pathology testing rate data that demonstrate the fall in testing areas (see details pictured). Significant decreases have been seen in clinical areas such as anaemia (down 29%) HbA1c tests for people with diabetes (down 14%) and prostate-specific antigen (PSA) prostate cancer (down 17%), among others.

BIVDA’s CEO, Doris-Ann Williams, said “The COVID pandemic has raised awareness of the importance of testing among the public higher than ever before, but people don’t always realise the significance of the information from tests on their routine blood samples – this information is critical to help doctors decide on treatment as well as diagnosis.

“We completely understand people’s fear of being infected with coronavirus and also not wishing to increase the burden on the NHS; however, they can be reassured by all the steps which have been made in healthcare settings to keep them safe. Ignoring new symptoms can mean that more extensive treatment is required which is a bigger burden to the NHS as well as potentially devastating to the individual and their family. So please Don’t Wait;Act”.

www.bivda.org.uk

 

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025